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Author disclosure of conflict of interest in vascular
surgery journals
Thomas L. Forbes, MD, London, Ontario, Canada
Objectives: Advances in vascular surgery are increasingly technology-driven, and the relationships between surgeons and
the medical device industry can be complex. This study reviewed conflict of interest (COI) disclosure in the vascular
surgery journals regarding several selected technology-driven topics, including endovascular stent grafts (EV), carotid
artery stenting (CAS), and peripheral arterial interventions (PI), to suggest further directions.
Methods: Authors’ COI disclosures were reviewed from all clinical papers published in 2008 and 2009 in each of six
vascular surgery journals, and pertaining to three selected topics (EV, CAS, and PI). Rate of COI disclosure was evaluated
as a function of journal, topic, article type (randomized trial, case series, case report, review, or meta-analysis), and
authors’ region of origin. Secondarily, consistency of authors’ disclosure was evaluated by reviewing papers by the same
author and of the same topic.
Results: Six hundred thirty-five papers were reviewed from the six journals. A COI was declared in 125 (19.7%) of these
papers. This rate differed between journals (range, 3.2%-34.1%; P < .0001). Rate of disclosure did not differ between
topics (range, 12.8%-21.2%; P .12), article type (range, 14.7%-30%; P .28), or region of origin (range, 0%-33.3%; P
.09). There were 116 instances of the same author writing papers describing the same general topic. COI disclosure was
consistent in the majority of these instances (72.4%), but inconsistent in 32 cases (27.6%). The most common (P  .006)
inconsistencies involved the same type of article in different journals (46.9%), or in the same journal (25%).
Conclusions: Rates of disclosure of COI, and inconsistencies in disclosure in the vascular surgery literature are at least
partially due to differences in journals’ reporting policies, while a smaller proportion of these inconsistencies are due to
individual author behavior. Journals should adopt a consistent requirement for a separate COI declaration where all
relevant financial arrangements are disclosed. (J Vasc Surg 2011;54:55S-8S.)
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pDiscussions regarding conflict of interest (COI) be-
tween the medical device industry and physicians are be-
coming increasingly common and intense. There is no
question that these relationships can bemutually beneficial,
and there are many instances of these collaborations result-
ing in advances in surgical technology and knowledge to
the benefit of our patients.1 However, these relationships
can also lead to real or perceived conflicts that can under-
mine patients’ trust in physicians,2 as well as the indepen-
dence of medical education3 and research.4-6 These truly
can be complex relationships.
Many medical and surgical subspecialties have explored
these issues in their published literature, including cardiac
surgery,7 cardiology,8 gastroenterology,9 and, probably
most extensively, orthopedic surgery.4,5,10-12 In the field of
vascular surgery, these often competing interests were ex-
tensively explored at the Crawford Critical Issues Forum at
the 2010 Vascular Annual Meeting in Boston. Speakers
representing vascular surgery, the medical device industry,
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xpressed their views regarding the current status of these
elationships.
In response to these issues, many major medical jour-
als, including the Journal of Vascular Surgery,13 instituted
andatory reporting of any potential conflict of interest
mong authors several years ago. Most major surgical jour-
als currently employ similar standards; however, reporting
f COIs appears to be variable among different journals.
here may be several explanations for this. The objective of
his review was to examine possible inconsistencies or vari-
bility between authors reporting of COI among vascular
urgery journals so that contributing factors might be rec-
gnized to arrive at suggestions for COI disclosure in the
uture.
ETHODS
The tables of contents of six vascular surgery journals
ere reviewed for all issues published in 2008 and 2009.
hree specific topics were the subject of this investigation as
hey represent major advances in surgical technologies, at
east partially as a result of collaborations between physi-
ians and industry. Papers chosen for subsequent review
ere limited to those describing endovascular abdominal or
horacic aortic stent grafts (EV), carotid artery stenting
CAS), or percutaneous interventions for peripheral arterial
isease (PI). Other areas, including venous disease, were
onsidered, but it was decided to restrict analysis to these
hree clinical areas as they represent a large proportion of
apers published in the vascular surgery literature. Follow-
ng a review of themethods section articles were classified as
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September Supplement 201156S Forbesone of four types of papers: randomized controlled trial
(RCT), case series, case report, or review/meta-analysis
(Table I).
Each paper was then reviewed to determine whether
the authors had disclosed a possible financial COI. The rate
of COI disclosure was analyzed with respect to journal,
topic, type of article, and authors’ region of origin. Addi-
tionally, consistency of COI disclosure was determined by
reviewing papers with the same corresponding or senior
author on the same topic.
Statistical analysis was performed with 2 test for pro-
portions with a P  .05 level of significance using Instat
3.06 software (GraphPad Software, San Diego, Calif). Re-
sults are presented such that the individual journals are not
identified.
RESULTS
During this 2-year period, 635 papers were analyzed
regarding author declaration of a COI. The majority of
papers were case series (n 430), while the remainder were
RCTs (n  10), case reports (n  129), and reviews or
meta-analyses (n  66). The most common topic was EV
(n 400), followed by CAS (n 118), and PI (n 117).
Half the papers originated from centers in North America
(n  317, 50%), while a third came from Europe and
Scandinavia (n  211, 33.2%).
Authors declared a COI in 125 of the 635 papers
(19.7%). This did not differ when considering topic (range,
12.8%-21.2%; P  .12), type of paper (range, 14.7%-30%;
P  .28), or geographic origin of the paper’s authors
(range, 0%-33.3%; P  .09). Although not statistically
Table I. Summary of methods
Topic Type of paper Origin of paper
Endovascular abdominal
or thoracic aortic
stent grafts
Carotid artery stenting
Peripheral interventions
for peripheral artery
disease
Randomized
controlled trial
Case series
Case report
Review or meta-
analysis
North America
South America
Europe and
Scandinavia
United Kingdom
Australia and New
Zealand
Far East
Africa
Table IIa. Conflict of interest disclosure by topic
(P  .12)
Topic
Number of
papers
Conflict of
interest disclosure %
Total 635 125 19.7
Endovascular abdominal or
thoracic aortic stent 400 85 21.2
Carotid artery stenting 118 25 21.2
Peripheral interventions for
peripheral artery disease 117 15 12.8significant, there was a trend toward less frequent declara- pion of COI in papers describing PI. Declaration of COI
id differ among the six journals, however, ranging from
.2% to 34.1% (P  .0001). Tables IIa-d summarize this
nformation.
After cross-referencing the principal authors, there
ere 116 instances of the same author writing at least two
apers with the same general topic (EV, CAS, or PI). COI
isclosure was consistent (either disclosure or no disclo-
ure) in 84 (72.4%) of these instances (Table III). There
ere 32 inconsistent sets of disclosures (27.6%), with the
ost common inconsistencies involving the same type of
aper in different journals (n  15, 46.9%) or the same
ournal (n  8, 25%).
ISCUSSION
Most interactions between physicians and industry are
eneficial to the advancement of science, and there are
any examples to support this. Although research takes
able IIb. Conflict of interest disclosure by type of
rticle (P  .28)
rticle type
Number of
papers
Conflict of
interest disclosure %
otal 635 125 19.7
andomized controlled trial 10 3 30
ase series 430 92 21.4
ase report 129 19 14.7
eview/meta-analysis 66 11 16.7
able IIc. Conflict of interest disclosure by region of
rigin (P  .09)
rigin
Number of
papers
Conflict of
interest disclosure %
otal 635 125 19.7
orth America 317 75 23.6
outh America 3 1 33.3
urope and Scandinavia 211 31 15.7
nited Kingdom 64 11 17.2
ustralia and New Zealand 15 5 33.3
ar East 24 2 9.2
frica 1 0 0
able IId. Conflict of interest disclosure by journal (P 
0001)
ournal
Number of
papers
Conflict of
interest disclosure %
otal 635 125 19.7
63 2 3.2
39 2 5.1
35 2 5.7
100 14 14.0
275 63 22.9
123 42 34.1lace in the laboratories of universities, hospitals, and com-
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Volume 54, Number 18S Forbes 57Smercial enterprises, it is usually only following physician
collaboration with industry that translation to beneficial
therapy is achieved.1 Many argue that these physician-
industry relationships can be ethically managed and, in fact,
are necessary for the advancement of medical science and
patient therapies.14 When asked, patients may also recog-
nize the necessity of these interactions and trust their
physicians to manage these relationships, rather than gov-
ernment or regulatory bodies.2
Unfortunately, however, the lines can be blurred. What
begins as a mutually beneficial and ethical relationship can
deteriorate into a conflict of interest most commonly as a
result of competing monetary issues and compensation.
Either party, physician, and/or industry, can precipitate
this, resulting in an erosion in the trust of physicians held by
patients, students, and the public. In the pharmaceutical
literature industry, employees have been listed as co-
authors with increasing frequency,15 and a general associa-
tion between medical and surgical clinical trial industry
funding and statistically significant proindustry findings has
been observed by some.6 A consistent and liberal disclosure
policy is necessary for maximum transparency.
In the medical device-related disciplines, orthopedic
surgery has been the most investigated specialty regarding
physician payments by device manufacturers. There is no
doubt that these financial relationships occur, but there has
been concern regarding the accuracy of their reporting. In
a recent study, lists of payments made to orthopedic sur-
geons by joint prostheses manufacturers were compared
with author reporting of these payments at a major ortho-
pedic national meeting.10 The disclosure rate of payments
directly related to the topic of the presentation was 79.3%,
with the most common reasons for nondisclosure being the
author believing the payment was not directly related to the
presentation (38.9%), or misunderstanding the reporting
requirements (13.9%). In a similar paper describing the
coronary stent literature, 83% of papers did not contain any
disclosure statement whatsoever. Also, only 3% of authors
Table III. Comparison of disclosure of COI by authors
of articles on same topic
Same author/topic sets Number % P
Total 116
Consistent COI 84 72.4
Inconsistent COI 32 27.6
Topic
Endovascular abdominal or thoracic
aortic stent grafts 28 87.5
Peripheral interventions for peripheral
artery disease 4 12.5
Pattern
Different journal and same type 15 46.9 .006
Same journal and different type 5 15.6
Different journal and type 4 12.5
Same journal and type 8 25
COI, Competition of interest.who did disclose a financial relationship with stent manu- facturers did so consistently in all their papers.8 Rather than
epresenting fewer financial relationships between cardiol-
gists and industry, these findings suggest a less strict
eporting policy by cardiology journals and an underreport-
ng by their authors.
The present study reviews the rate and consistency of
OI reporting in the vascular surgery literature. This re-
iew was restricted to papers involving the device-related
opics of EV, CAS, and PI. One-fifth (19.7%) of papers
ncluded a COI disclosure, which is a similar rate as that
eported in the orthopedic5 and gastroenterology9 litera-
ure. Although there was a trend toward fewer disclosures
n PI papers, there was no statistical difference between
hese three topics. Possible explanations for this trend
nclude the relative recent growth of the PI industry, rela-
ive to stent grafts, such that these industry-physician rela-
ionships may not have developed yet to the same fre-
uency or extent as other clinical areas with a longer
istory. That is, COI is declared less often with PI papers
ecause it truly does not exist. In addition, it is possible that
he primary author’s specialty may contribute to the likeli-
ood of COI existence and disclosure. Although not inves-
igated as part of this study, it is proposed that vascular
urgeons are more likely to author papers describing stent
rafts, while nonsurgeons contribute more papers describ-
ng peripheral interventions. Whether author specialty is a
eterminant of the likelihood of a COI or its subsequent
isclosure is yet to be determined and was beyond the focus
f this paper.
Neither article type, whether it be a case report or RCT,
r region of origin influenced this rate of COI disclosure.
alf the papers were from North American authors, and
everal regions had few papers (ie, South America), but
egion of origin did not influence the rate of COI disclosure
n this study. Rates of disclosure were consistent world-
ide.
Rates of COI disclosure did differ, however, between
he six vascular surgery journals, ranging from 3.2% to
4.1%. There are a number of possible explanations for this.
irst of all, although the six journals are general vascular
urgery journals, the scope of publication differs slightly
etween them. Some of them could be seen as having a
ore technology-driven theme that might attract papers
rom authors who are more likely to work closely with
ndustry. Secondly, the journals are of varying impact fac-
ors. Those with the higher impact factors might attract
ubmissions from more senior or experienced authors who
remore likely to have a relationship with industry based on
he length and productivity of their surgical and academic
areers. These possible explanations are the result of obser-
ations from this study, and data to prove them are beyond
he scope of this study.
Another reason for the observed variation in COI re-
orting between the journals pertains to the journals’ re-
orting guidelines and processes themselves. The COI
isclosure processes of these journals include mandatory
ompletion of separate authors’ role and COI disclosure
orms, mandatory inclusion of a statement of disclosure or
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September Supplement 201158S Forbesnondisclosure in a cover letter, or voluntary inclusion of a
disclosure statement. Those journals requiring separate
forms or statements tended to have higher rates of disclo-
sure than those that did not, suggesting some confusion on
the authors part as a result of these different processes.
In the vast majority of instances, COI disclosure was
consistent when authors published more than one paper
describing the same topic. Authors either consistently re-
ported a COI or no COI in all papers in 72.4% of instances.
Of course, it is difficult, if not impossible, to determine
whether reporting consistency equals accuracy. In the re-
maining 27.6% of instances, there was inconsistency in COI
disclosure by authors of papers with the same topic. Close
to half of these inconsistencies (46.9%) were instances of
the same type of paper in different journals, suggesting that
journal reporting processes are contributory. In another
quarter of the instances of disclosure inconsistency, the
same type of article was published in the same journal.
These instances may reflect author specific issues, such as
confusion or uncertainty regarding the relevance of a finan-
cial relationship to a paper’s topic.
This study has several methodological limitations. It is
an observational study limited to a 2-year publication win-
dow and three topics specific to vascular surgery, so the
results may not be generalizable to other areas. The study
cannot comment on the extent or degree of COI as the
observations were restricted to the presence or absence of a
COI disclosure. Additionally, by the nature of a 2-year
publication window and by restricting the study to six
specific journals, the instances of multiple publications by
the same authors are likely underreported.
Vascular surgery will continue to be a technology-
dependant specialty with advances requiring collaboration
between individual practitioners and industry. Although
the term “conflict of interest” has negative connotations,
these relationships are not inherently bad, but they do
require accurate reporting so that readers themselves can
determine their relevance or irrelevance. Disclosure of these
relationships needs to be consistent and accurate to permit
an unbiased interpretation of the literature. The differences
in conflict of interest reporting between the different vas-
cular surgery journals suggests the need for mandatory
completion of a separate COI disclosure form for all journal
articles. Some inconsistencies in COI disclosure will con-
tinue to be due to author issues, such as confusion over
guidelines and processes or questions of relevance. In these
instances authors should be encouraged to overreport,
rather than fail to report, any possible or perceived conflict
of interest.
CONCLUSIONS
Relationships between physicians and the medical de-
vice industry are necessary to ensure appropriate and safe Sevelopment of novel therapies. Whether these relation-
hips constitute a conflict of interest should be determined
y the readers, not the authors who should disclose all
nancial relationships with any possible relevance to the
aper in question.
As journal reporting policies partially determine rate of
isclosure, vascular surgery journals should adopt a uni-
orm requirement for a separate financial relationship re-
orting document for all paper submissions in order to
inimize author confusion.
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